Insulet Corp. tapped Peter Devlin, a veteran medical device industry executive, to leads its commercial strategy operation.
The Bedford, Mass.-based insulin management system maker said its new chief commercial officer will lead its sales & marketing, business development, clinical research and customer care operations.
Devlin spent 11 years at Abbott Laboratories, ending his tenure there as divisional vice president of global strategic marketing for its diabetes care business. He also put in stints at i-Stat Corp. (later acquired by Abbott) and at C.R. Bard Inc.